Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Rajeev Shrestha, Sunil Shrestha, Binaya Sapkota, Santosh Thapa, Mukhtar Ansari, Asmita Priyadarshini Khatiwada, Rohullah Roien & Akihiko Ozaki. (2022) Generic Medicine and Generic Prescribing in Nepal: An Implication for Policymakers. Journal of Multidisciplinary Healthcare 15, pages 365-373.
Read now
Read now
Ieva Salmane Kulikovska, Elita Poplavska, Marija Ceha & Signe Mezinska. (2019) Use of generic medicines in Latvia: awareness, opinions and experiences of the population. Journal of Pharmaceutical Policy and Practice 12:1.
Read now
Read now
Kyriakos Souliotis, Christina Golna, Chara Kani & Sophia Markantonis. (2019) Exploring knowledge and perceptions on generic drugs of final year pharmacy school students in Greece. Expert Review of Pharmacoeconomics & Outcomes Research 19:5, pages 569-574.
Read now
Read now
Loc Phuoc Thai, Agnes Isabelle Vitry & John Robert Moss. (2018) Price and utilisation differences for statins between four countries. Expert Review of Pharmacoeconomics & Outcomes Research 18:1, pages 71-81.
Read now
Read now
Joseph O Fadare, Adekunle O. Adeoti, Olufemi O. Desalu, Okezie O. Enwere, Aliyu M. Makusidi, Olayinka Ogunleye, Taofiki A. Sunmonu, Ilse Truter, Onyinye O Akunne & Brian Godman. (2016) The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert Review of Pharmacoeconomics & Outcomes Research 16:5, pages 639-650.
Read now
Read now
Guenka Petrova, Miglena Doneva, Zornica Mitkova, Konstantin Tachkov & Manoela Manova. (2016) Generics and fixed-dose combinations in cardiology: satisfaction analysis of pharmacists and cardiologists. Biotechnology & Biotechnological Equipment 30:1, pages 204-211.
Read now
Read now
Hye-Young Kwon, Hyungmin Kim, Brian Godman & Michael R Reich. (2015) The impact of South Korea’s new drug-pricing policy on market competition among off-patent drugs. Expert Review of Pharmacoeconomics & Outcomes Research 15:6, pages 1007-1014.
Read now
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2015) Societal value of generic medicines beyond cost-saving through reduced prices. Expert Review of Pharmacoeconomics & Outcomes Research 15:4, pages 701-711.
Read now
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2015) Analysis of the Italian generic medicines retail market: recommendations to enhance long-term sustainability. Expert Review of Pharmacoeconomics & Outcomes Research 15:1, pages 33-42.
Read now
Read now
Alian A Alrasheedy, Mohamed Azmi Hassali, Kay Stewart, David CM Kong, Hisham Aljadhey, Mohamed Izham Mohamed Ibrahim & Saleh Karamah Al-Tamimi. (2014) Patient knowledge, perceptions, and acceptance of generic medicines: a comprehensive review of the current literature. Patient Intelligence 6, pages 1-29.
Read now
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2014) Analysis of French generic medicines retail market: why the use of generic medicines is limited. Expert Review of Pharmacoeconomics & Outcomes Research 14:6, pages 795-803.
Read now
Read now
Pieter Dylst, Arnold G Vulto & Steven Simoens. (2014) Analysis of Spanish generic medicines retail market: recommendations to enhance long-term sustainability. Expert Review of Pharmacoeconomics & Outcomes Research 14:3, pages 345-353.
Read now
Read now
Articles from other publishers (35)
Heberto R. Priego Álvarez, María Isabel Ávalos García, Silvia María Guadalupe Garrido Pérez & Christian Amor García Montes. (2023) Medicamentos genéricos ¿buenos y usables? La percepción de los estudiantes de medicina en un estado mexicano. Gaceta Médica Boliviana 46:1, pages 59-66.
Crossref
Crossref
Waad O Mahmoud Soliman, Abdalla I Shehata & Rasha A Mosallam. (2022) International Nonproprietary Names prescription in a specialized public hospital in Egypt. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 18:4, pages 223-232.
Crossref
Crossref
Jinghan Qu, Wei Zuo, Roxane L. Took, Kenneth W. Schafermeyer, Stephanie Lukas, Shaohong Wang, Liping Du, Xin Liu, Yang Gao, Jiantao Li, Hui Pan, Xiaoli Du, Dan Mei & Bo Zhang. (2022) A nationwide survey exploring physicians’ and pharmacists’ knowledge, awareness and perceptions regarding generic medicines in China. BMC Health Services Research 22:1.
Crossref
Crossref
Ammar Ali Saleh Jaber, Yaser Mohammed Al-Worafi & Abdullah Ahmed Dhabali. (2021) Patients’ beliefs toward generic medication in Yemen. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 18:2, pages 110-115.
Crossref
Crossref
Jacopo Lenzi & Maria Michela Gianino. (2022) Switch from public to private retail pharmaceutical expenditures: evidence from a time series analysis in Italy. BMJ Open 12:3, pages e055421.
Crossref
Crossref
Imen GuellaNageeb Hassan, Moyad ShahwanYaser Mohammed Al-WorafiSahab Alkhoujah. (2021) Patients’ beliefs towards generic medicines in the United Arab Emirates. Research Journal of Pharmacy and Technology, pages 3343-3346.
Crossref
Crossref
VerinderJit Singh Virdi, Money Gupta & Rohit Gupta. (2021) Hurdles in mandatory generic medicine prescription. Journal of Pharmacology and Pharmacotherapeutics 12:3, pages 115.
Crossref
Crossref
Ana Kodrič, Igor Locatelli & Mitja Kos. (2020) The impact of reference pricing on healthcare outcomes in patients with arterial hypertension. Health Policy and Technology.
Crossref
Crossref
Caridad Pontes, Corinne Zara, Josep Torrent-Farnell, Merce Obach, Cristina Nadal, Patricia Vella-Bonanno, Michael Ermisch, Steven Simoens, Renata Curi Hauegen, Jolanta Gulbinovic, Angela Timoney, Antony P. Martin, Tanja Mueller, Anna Nachtnebel, Stephen Campbell, Gisbert Selke, Tomasz Bochenek, Celia C. Rothe, Ileana Mardare, Marion Bennie, Jurij Fürst, Rickard E. Malmstrom & Brian Godman. (2019) Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab. Applied Health Economics and Health Policy 18:1, pages 5-16.
Crossref
Crossref
Mohamed Izham Mohamed Ibrahim & Ahmed Awaisu. 2020. Global Pharmaceutical Policy. Global Pharmaceutical Policy
53
72
.
Sabine Vogler, Guillaume Dedet & Hanne Bak Pedersen. (2019) Financial Burden of Prescribed Medicines Included in Outpatient Benefits Package Schemes: Comparative Analysis of Co-Payments for Reimbursable Medicines in European Countries. Applied Health Economics and Health Policy 17:6, pages 803-816.
Crossref
Crossref
Sabine Vogler. (2019) Fair prices for medicines? Exploring competent authorities’ and public payers’ preferences on pharmaceutical policies. Empirica 46:3, pages 443-469.
Crossref
Crossref
Warren A. Kaplan, Jorge Cárdenas, Cristián Mansilla, Tatiana Tobar & Veronika J. Wirtz. (2019) The implementation of the bioequivalence certification policy in Chile: An analysis of market authorization data. PLOS ONE 14:5, pages e0217334.
Crossref
Crossref
Eriko Kobayashi, Chiemi Abe & Nobunori Satoh. (2018) Patients’ perspectives on generic substitution among statin users in Japan. Journal of Public Health 27:1, pages 11-19.
Crossref
Crossref
Chalachew Alemayehu, Geoff Mitchell, Jane Nikles, Abraham Aseffa & Alexandra Clavarino. (2018) Views and perceptions about locally manufactured medicines in Ethiopia: a qualitative study of physicians, patients and regulatory authorities. BMC Health Services Research 18:1.
Crossref
Crossref
Mohamed Azmi Hassali & Zhi Yen Wong. 2018. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries
197
210
.
Nada Abdel Rida & Mohamed Izham Mohamed Ibrahim. 2018. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries
111
128
.
Sabine Vogler, Margit Gombocz & Nina Zimmermann. (2017) Tendering for off-patent outpatient medicines: lessons learned from experiences in Belgium, Denmark and the Netherlands. Journal of Pharmaceutical Health Services Research 8:3, pages 147-158.
Crossref
Crossref
OLIVIER J. WOUTERS, PANOS G. KANAVOS & MARTIN McKEE. (2017) Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending. The Milbank Quarterly 95:3, pages 554-601.
Crossref
Crossref
Sabine Vogler, Valérie Paris, Alessandra Ferrario, Veronika J. Wirtz, Kees de Joncheere, Peter Schneider, Hanne Bak Pedersen, Guillaume Dedet & Zaheer-Ud-Din Babar. (2017) How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. Applied Health Economics and Health Policy 15:3, pages 307-321.
Crossref
Crossref
Alicia Molinier, Aurore Palmaro, Vanessa Rousseau, Agn?s Sommet, Robert Bourrel, Jean-Louis Montastruc & Haleh Bagheri. (2016) Does substitution of brand name medications by generics differ between pharmacotherapeutic classes? A population-based cohort study in France. European Journal of Clinical Pharmacology 73:4, pages 471-477.
Crossref
Crossref
Zhi Yen Wong, Alian A. Alrasheedy, Mohamed Azmi Hassali & Fahad Saleem. (2016) Generic medicines in the Malaysian health care system: Opportunities and challenges. Research in Social and Administrative Pharmacy 12:5, pages 807-810.
Crossref
Crossref
Sabine Vogler, Nina Zimmermann & Katharina Habimana. (2016) Stakeholder preferences about policy objectives and measures of pharmaceutical pricing and reimbursement. Health Policy and Technology 5:3, pages 213-225.
Crossref
Crossref
Racha Fadlallah, Hala Nas, Dana Naamani, Fadi El-Jardali, Ihsan Hammoura, Lina Al-Khaled, Hneine Brax, Lara Kahale & Elie A. Akl. (2016) Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review. PLOS ONE 11:8, pages e0160540.
Crossref
Crossref
Loc P. Thai, Agnes I. Vitry & John R. Moss. (2016) Pricing and utilisation of proton pump inhibitors in South Australian public hospitals and the Pharmaceutical Benefits Scheme. Journal of Pharmacy Practice and Research 46:2, pages 130-136.
Crossref
Crossref
A. O’Leary, C. Usher, M. Lynch, M. Hall, L. Hemeryk, S. Spillane, P. Gallagher & M. Barry. (2015) Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland. BMC Research Notes 8:1.
Crossref
Crossref
Еmilova Mitkova Zornitza, Tihomirov Tachkov Konstantin, Ivanova Petrova Guenka & Metodieva Manova Manoela. (2015) Factors influencing generics and fixed dose combinations recommendation by pharmacists for cardiology patients. African Journal of Pharmacy and Pharmacology 9:43, pages 1020-1025.
Crossref
Crossref
Olivier J WoutersPanos G Kanavos. (2015) Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform. Bulletin of the World Health Organization 93:9, pages 606-613.
Crossref
Crossref
Valérie Piguet, Stéphanie D’Incau, Marie Besson, Jules Desmeules & Christine Cedraschi. (2015) Prescribing Generic Medication in Chronic Musculoskeletal Pain Patients: An Issue of Representations, Trust, and Experience in a Swiss Cohort. PLOS ONE 10:8, pages e0134661.
Crossref
Crossref
Zhi Yen Wong, Mohamed Azmi Hassali, Alian A. Alrasheedy, Fahad Saleem, Abdul Haniff Mohamad Yahaya & Hisham Aljadhey. (2014) Malaysian generic pharmaceutical industries: perspective from healthcare stakeholders. Journal of Pharmaceutical Health Services Research 5:4, pages 193-203.
Crossref
Crossref
Panos Kanavos. (2014) Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States. Health Policy 118:2, pages 229-241.
Crossref
Crossref
Mohamed Azmi Hassali, Zhi Yen Wong, Alian A. Alrasheedy, Fahad Saleem, Abdul Haniff Mohamad Yahaya & Hisham Aljadhey. (2014) Perspectives of physicians practicing in low and middle income countries towards generic medicines: A narrative review. Health Policy 117:3, pages 297-310.
Crossref
Crossref
Sabine Vogler, Katharina Habimana & Danielle Arts. (2014) Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries. Health Policy 117:3, pages 311-327.
Crossref
Crossref
Pieter Dylst, Arnold Vulto, Brian Godman & Steven Simoens. (2013) Generic Medicines: Solutions for a Sustainable Drug Market?. Applied Health Economics and Health Policy 11:5, pages 437-443.
Crossref
Crossref
Jette Rathe, Pia Larsen, Morten Andersen, Maja Paulsen, Dorte Jarbøl, Janus Thomsen & Jens Soendergaard. (2013) Associations between generic substitution and patients' attitudes, beliefs and experiences. European Journal of Clinical Pharmacology 69:10, pages 1827-1836.
Crossref
Crossref